Oncotarget. 2017 Jun 16;8(45):79507-79516. doi: 10.18632/oncotarget.18525. eCollection 2017 Oct 03.
Surgical management for follicular variant of papillary thyroid carcinoma.
Oncotarget
Jianing Tang, Deguang Kong, Lupin Bu, Gaosong Wu
Affiliations
Affiliations
- Department of Breast and Thyroid Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P.R. China.
- Department of General Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P.R. China.
PMID: 29108330
PMCID: PMC5668063 DOI: 10.18632/oncotarget.18525
Abstract
BACKGROUND AND AIMS: For most patients with follicular variant of papillary thyroid carcinoma (FVPTC), surgery is required, while the surgical management remains controversial. We aim to further understanding of treatment of FVPTC and to determine whether specific features could be identified for the decision of surgical strategy.
MATERIALS AND METHODS: Data were obtained from the Surveillance, Epidemiology, and End Results (SEER) Program database during 2003 and 2013. 26700 patients were eligible and stratified by tumor size or extension. Survival rates were compared using multivariate Cox proportional hazard regressions.
RESULTS: Of the total death of 1041, 136 patients died from thyroid cancer. Most patients (79.1%) underwent total thyroidectomy while only a little part of patients (8.2%) underwent lobectomy. Patients receiving radioisotopes had significantly better overall survival (OS) (HR = 0.659,
CONCLUSIONS: The results of our study revealed total thyroidectomy could benefit the survival for patients whose tumors > 2 cm with extrathyroidal extension, total thyroidectomy should be recommended for those patients. Lots of factors should be taken into consideration on the decision of surgical treatment.
Keywords: SEER; follicular variant of papillary thyroid carcinoma; surgery
Conflict of interest statement
CONFLICTS OF INTEREST The authors have no conflicts of interest to disclose.
References
- Cancer. 2006 Sep 15;107(6):1255-64 - PubMed
- Am J Clin Pathol. 2002 Jan;117(1):16-8 - PubMed
- Clin Endocrinol (Oxf). 2011 Jul;75(1):112-9 - PubMed
- Jpn J Clin Oncol. 2006 Nov;36(11):688-93 - PubMed
- Cancer. 2003 Mar 1;97(5):1181-5 - PubMed
- Ann Surg Oncol. 2014 Nov;21(12):3844-52 - PubMed
- Cancer. 1979 Mar;43(3):810-20 - PubMed
- Eur J Cancer. 1979 Aug;15(8):1033-41 - PubMed
- Thyroid. 1994 Summer;4(2):233-6 - PubMed
- Ann Surg. 2007 Sep;246(3):375-81; discussion 381-4 - PubMed
- Surgery. 2004 Sep;136(3):609-16 - PubMed
- Thyroid. 2016 Jul;26(7):872-4 - PubMed
- Surgery. 2017 Jan;161(1):137-146 - PubMed
- Thyroid. 2016 Jan;26(1):1-133 - PubMed
- Arch Surg. 2003 Dec;138(12):1362-6 - PubMed
- Thyroid. 2013 Oct;23 (10 ):1263-8 - PubMed
- Cancer. 1998 Sep 1;83(5):1012-21 - PubMed
- World J Surg. 2006 May;30(5):752-8 - PubMed
- Clin Oncol (R Coll Radiol). 2017 May;29(5):290-297 - PubMed
- Ann Surg Oncol. 2015 Jan;22(1):158-63 - PubMed
- J Clin Endocrinol Metab. 1996 Jan;81(1):333-9 - PubMed
- J Clin Endocrinol Metab. 2015 Jan;100(1):115-21 - PubMed
- Surgery. 1994 Dec;116(6):1036-40; discussion 1040-1 - PubMed
- Ann Surg. 1953 Jul;138(1):33-8 - PubMed
- Eur J Surg Oncol. 2017 Jan 19;:null - PubMed
- Ann Surg Oncol. 1996 Nov;3(6):534-8 - PubMed
- Endocr Pathol. 2005 Winter;16(4):323-30 - PubMed
- Cancer. 1985 Feb 15;55(4):805-28 - PubMed
Publication Types